Immunology E-Learning Course

This module of the Rare Diseases Immunology course provides an overview of the immune system and the immune response, including types of immunity and key elements of the immune system. It also defines the concept of primary immunodeficiency.

Upon completion of this module, you should be able to:

• Recall the key components of the immune system involved in primary immunodeficiency (PI)
• Define the basics of PI disease (PID)

This module takes approximately 30 minutes to complete.

This module of the Rare Diseases Immunology course examines primary immunodeficiency (PI) in detail, by presenting the different types of PI, the symptoms of PI, how they are diagnosed, and how they are treated.

Upon completion of this module, you should be able to:

• Discuss the epidemiology and occurrence of PI
• List and describe the different categories of PI disease states
• Outline the warning signs of PI
• Discuss the diagnosis of PI
• List the general treatment options of PI

This module takes approximately 1.5 hours to complete.

This module of the Rare Diseases Immunology course reviews various plasma-derived treatments – which include a number of Takeda products, such as immunoglobulin (IG) therapy. This module discusses the different diseases that these types of plasma-derived products are used for, and the sources of these products.

Upon completion of this module, you should be able to:

• Identify and provide an overview of examples of Takeda plasma-derived treatments
• Explain where plasma-derived treatments come from

This module takes approximately 30 minutes to complete.

This module of the Rare Diseases Immunology course investigates Multifocal Motor Neuropathy (MMN). It confirms the definition of MMN – its prevalence and disease course, its clinical presentation; as well as the diagnosis, differential diagnosis and current treatment options for managing various MMN patients.

Upon completion of this module, you should be able to:

• Define MMN and list clinical features and symptoms associated with MMN
• Describe the pathophysiology of MMN
• Discuss the diagnosis of MMN
• List the general treatment options for MMN

This module takes approximately 1.5 hours to complete.

This module of the Rare Diseases Immunology course explains the mechanism of action (MOA) by which immunoglobulin therapy (IG) effectively treats patients with primary immunodeficiency (PI). The module includes an overview of PI as a disease state, the management of PI with IG treatment, and how IG replacement works in treating antibody production deficiency.

Upon completion of this module, you should be able to:

• Describe PI in terms of antibody production deficiency
• Explain the MOA by which IG replacement is used to treat patients with PI with antibody deficiencies

This module takes approximately 30 minutes to complete.

This module of the Rare Diseases Immunology course explains the different routes of administration (ROA) of immunoglobulin (IG) treatments, including the important aspects and background of these various medical treatments.

Upon completion of this module, you should be able to:

• Describe the key features and history of intravenous infusion of IG treatment
• Describe the key features and history of conventional subcutaneous infusion of IG treatment
• Describe the key features and history of facilitated subcutaneous infusion of IG treatments

This module takes approximately 1 hour to complete.

This module of the Rare Diseases Immunology course reviews how plasma-derived therapeutic products are produced, including the methods of plasma collection, fractionation, and fine-finishing. This module also presents details about the criteria needed to qualify as a plasma donor and Takeda’s IG manufacturing processes around the world.

Upon completion of this module, you should be able to:

• Describe the plasma collection process used for Takeda’s plasma-derived therapeutic products
• Explain how collected plasma is fractionated for Takeda’s plasma-derived therapeutic products
• Explain Takeda’s fine-finishing process for IG treatments

This module takes approximately 30 minutes to complete.